Support your body with the fundamentals: regular sleep, a nutrient-rich diet, stress management, and exercise consistency
(ClinicalTrials.gov number: NCT03488485) Disclosures: Radha Dhiman: Nothing to Disclose, Madhumita Premkumar: Nothing to Disclose, Jasvinder Nain: Nothing to Disclose, Ajay Duseja: Nothing to Disclose, EkTA Gupta: Nothing to Disclose, Sahaj Rathi: Nothing to Disclose, SUNIL TANEJA: Nothing to Disclose, Surender Singh: Nothing to Disclose, Akash Roy: Nothing to Disclose, Anchal Sandhu: Nothing to Disclose, Prerna Sharma: Nothing to Disclose, Gagandeep Singh Grover: Nothing to Disclose 2622 CLINICAL AND GENETIC CHARACTERISTICS OF PATIENTS WITH HISTOLOGIC STEATOSIS DEFINED BY NATURAL LANGUAGE PROCESSING IN THE MVP LIVER BIOPSY COHORT Samiran Mukherjee 1 Patrick Alba 2 Anthony Gao 3 Craig Teerlink 3 David Kaplan 4 K Rajender Reddy 4 Tia Dinatale 3 Timothy Morgan 5 Saiju Pyarajan 6 Daniel Dochtermann 6 Marijana Vujkovic 1 Julie Lynch 3 Kyong-Mi Chang 1 , 1 Philadelphia VAMC, UPenn, 2 VINCI, 3 VINCI, VA Salt Lake City, 4 University of Pennsylvania, 5 VA Long Beach Healthcare System, 6 VA Boston Healthcare System Background: Metabolic-Associated Steatotic Liver Disease (MASLD) is a leading cause of chronic liver disease (CLD)
Eczema and other inflammatory skin conditions can also cause discoloration
In summary, utilizing PCLS to further our understanding of molecular events and explore various therapeutic options for post-LTx lung IRI represents a promising avenue for future research in this field
